New patent reform bill
Executive Summary
Sen. Jon Kyl, R-Ariz., plans to introduce a patent damages bill that does not include the apportionment provisions opposed by drug lobbyists and contained in legislation sponsored by Sen. Patrick Leahy, D-Vt. (S. 1145). The House and Senate Judiciary Committees each approved versions of Leahy's bill in July 2007, but the bill has since stalled (1"The Pink Sheet," July 23, 2007, p. 20). Leahy's bill would require courts to select one of several methods of calculating royalties. Kyl's legislation, which the senator plans to introduce in September, would codify the so-called "Georgia-Pacific factors": 15 factors for calculating royalty payments for patents, established in a 1970 federal court case...
You may also be interested in...
Patent Reform Bills Clear House And Senate Judiciary Committees
The House and Senate Judiciary Committees each approved versions of patent reform legislation the week of June 16 that respond to some concerns raised by drug and medical device lobbyists, but that still leave industry unsatisfied and primed to seek changes before the bills go to a floor vote
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.